Citation Impact
Citing Papers
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
2006
Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
2016 Standout
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Genetic variation inCLDN1and susceptibility to hepatitis C virus infection
2009 StandoutNobel
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
2023 StandoutNobel
Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry
2009
Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆
2011
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
2011
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Cell entry of hepatitis C virus
2006
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
2012
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells
2005
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
2008 StandoutNobel
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses
2014
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Hepatitis C Virus Entry
2007 StandoutNobel
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Neutralizing Antibodies Induced by Cell Culture–Derived Hepatitis C Virus Protect Against Infection in Mice
2013
Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion
2008
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells
2008
Hepatitis C Virus Entry
2013
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
2007
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins
2007
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
2013 StandoutNobel
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
2020 Standout
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Daniel Steinmann being referenced
PEEP titration guided by ventilation homogeneity: a feasibility study using electrical impedance tomography
2010
Electrical impedance tomography to confirm correct placement of double-lumen tube: a feasibility study
2008
Evaluation of an electrical impedance tomography-based global inhomogeneity index for pulmonary ventilation distribution
2009
Electrical impedance tomography for verification of correct endotracheal tube placement in paediatric patients: a feasibility study
2013
Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C
2004
A lung area estimation method for analysis of ventilation inhomogeneity based on electrical impedance tomography
2010